BioSpace News Archive

Drug Development

Renibus Therapeutics Announces Breakthrough Therapy Designation from US FDA for RBT-1 for the Reduction in Risk of Post-Operative Complications in Patients Undergoing Cardiothoracic Surgery

Renibus Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to RBT-1 for the reduction in risk of post-operative complications in patients undergoing cardiothoracic surgery, and confirmed its alignment with the Company’s planned Phase 3 pivotal trial.

July 11, 2023
·
3 min read
Pharm Country

American Liver Foundation Announces New Liver Research Awards for 2023

The American Liver Foundation announced new liver research awards for 2023 that will fund early career scientists interested in basic and translational research.

July 11, 2023
·
4 min read
Business

Stanford University Joins Cofactor Genomics’ Clinical Trial Evaluating Immunotherapy Predictive Diagnostic Assay Across 11 Cancers

Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced that Stanford will join Cofactor’s PREDAPT clinical trial evaluating use of the company’s OncoPrism™ predictive diagnostic assay across 11 cancers.

July 11, 2023
·
2 min read
Drug Development

IconOVir Bio Announces First Patient Dosed in Phase 1 Clinical Trial of its Lead Product Candidate, ICVB-1042

IconOVir Bio, Inc. today announced that the first patient has been dosed in a Phase 1 dose escalation and expansion clinical trial evaluating intravenously (IV) administered ICVB-1042 for the treatment of advanced solid tumors.

July 11, 2023
·
3 min read
Drug Development

MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology, Inc. (NYSE American: MAIA) today announced updates on disease control data in the Part A safety lead-in of its ongoing THIO-101 phase 2 trial, evaluating THIO in sequential combination with cemiplimab in patients with advanced Non-Small Cell Lung Cancer (NSCLC).

July 11, 2023
·
5 min read
Business

Salix Announces 2023 Gastrointestinal Health Scholars Program Winners

Bausch Health Companies Inc. (NYSE/TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced the winners of its 2023 Salix Gastrointestinal Health Scholars Program.

July 11, 2023
·
4 min read
Deals

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

MEI Pharma, Inc. (NASDAQ: MEIP) (the “Company”) today reminded shareholders to vote FOR the Company’s pending transaction with Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”) in connection with the upcoming special meeting on July 14, 2023.

July 11, 2023
·
11 min read
FDA

AccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance

AccurKardia announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance.

July 11, 2023
·
3 min read
Pharm Country

CoJourney Inc. Secures $30 Million Financing and Announces Expansion of US Operations: High Quality, Cost Effective, Commercial Scale Manufacturing Platform for Cell and Gene Therapies

CoJourney Inc. a global innovator in manufacturing and development of cell and gene therapies is pleased to announce completion of a $30 M Series A financing and expansion of its US organization and commercial manufacturing capabilities.

July 11, 2023
·
3 min read
Business

Lisata Therapeutics Announces Retirement of Dr. Erkki Ruoslahti from Board of Directors

Lisata Therapeutics, Inc. today announced that Erkki Ruoslahti, M.D., Ph.D., has decided to retire from its Board of Directors effective today, July 11, 2023.

July 11, 2023
·
3 min read